Arkolith/Insider Trading/AUPH/Form 4

Keenan Greg

Chief Medical OfficerAurinia Pharmaceuticals Inc. (AUPH) · full profile →Form 4 · filed Mar 7, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$68K
Net Open-Market Flow
-$68K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 7, 2025Sell(S)8K$8.23$68K153K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001600620-25-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML